We focus on venture creation of biotechnology and pharmaceutical drug discovery & development companies. Our philosophy is based on the fundamentals of venture creation and due diligence to launch relatively mature and vetted start-up companies. We build value with experienced executives and drug development teams, focused scientific and development milestones, active advisors, and a virtual or quasi-virtual business model for capital efficiency.
Portfolio companies: Gate Neurosciences, Anagin, other stealth mental health focused companies in progress; Assembly Pharmaceuticals (now Assembly Biosciences, Nasdaq: ASMB); Assembly China, Naurex (Acquired by Allergan), Aptinyx (Nasdaq: APTX; Naurex spin out); Coferon/Blink Bio, others not disclosed.
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
2007
Founded
Investors
0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
When was Luson Bioventures founded?
Luson Bioventures was founded in 2007.
What industry is Luson Bioventures in?
Luson Bioventures operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Find investors for your startup like Luson Bioventures
Gritt sends AI-personalised outreach to each investor — from your Gmail
